Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Income Statement [Abstract]    
Revenues $ 3,069,271 $ 1,396,751
Cost of goods sold 2,711,644 1,294,347
Gross margin 357,627 102,404
Operating expenses    
Operations 1,048,086 176,863
Research and development 532,770 244,254
Sales and marketing 602,231 100,633
General and administrative 1,117,565 876,180
Stock based compensation 755,471 384,086
Total operating expenses 4,056,123 1,782,016
Operating loss (3,698,496) (1,679,612)
Other expense (income)    
Change in fair value of derivative liability 92,922 (154,248)
Investment income, net (130,296)
Interest expense 35,687 17,099
Other, net 114,790 15,309
Other expense (income) 113,103 (121,840)
Net loss $ (3,811,599) $ (1,557,772)
Loss per share - basic and diluted $ (0.07) $ (0.05)
basic and diluted 53,778,154 34,074,226